The prognostic value of the mir-200 family in ovarian cancer: a meta-analysis
|
|
- Clarence Taylor
- 5 years ago
- Views:
Transcription
1 AOGS REVIEW ARTICLE The prognostic value of the mir-200 family in ovarian cancer: a meta-analysis CAN SHI & ZHENYU ZHANG Department of Obstetrics and Gynecology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China Key words Meta-analysis, mir-200, ovarian cancer, survival Correspondence Zhenyu Zhang, Department of Obstetrics and Gynecology, Beijing Chao-Yang Hospital, Capital Medical University, No. 8 Gongti SouthRoad, Chaoyang District, Beijing , China zhenyuzhang64@163.com Conflict of interest All authors have stated explicitly that there are no conflicts of interest in connection with this article. Please cite this article as: Shi C, Zhang Z. The prognostic value of the mir-200 family in ovarian cancer: a meta-analysis. Acta Obstet Gynecol Scand 2016; 95: Received: 3 November 2015 Accepted: 25 January 2016 DOI: /aogs Abstract Introduction. To assess the association between mir-200 family expression and overall survival/progression-free survival in women with ovarian cancer. Material and methods. A systematic literature search, up to September 2015, in PubMed, EMBASE and Cochrane Library was performed to identify articles that assessed the association between mir-200 family expression and the survival of women with ovarian cancer. Summary hazard ratios and 95% confidence interval were calculated to estimate the effect. Results. A total of seven articles, consisting of 553 women, were included in this meta-analysis. Overall, significantly improved overall survival/progression-free survival were observed with higher expression of the mir-200 family in women with ovarian cancer (overall survival, hazard ratio = 0.34, 95% confidence interval ; progression-free survival, hazard ratio = 0.64, 95% confidence interval ). Subgroup analysis revealed that there was a significant association between enhanced expression of the mir-200c and improved overall survival (hazard ratio = 0.20, 95% confidence interval ) and progression-free survival (hazard ratio = 0.30, 95% confidence interval ). Moreover, in the Asian population, a significant association was found between higher expression of the mir-200 family and improved overall survival (hazard ratio = 0.20, 95% confidence interval ). Conclusion. High expression of mir-200c may predict improved survival in women with ovarian cancer and high expression of the mir-200 family significantly improves overall survival for Asian women. Abbreviations: HRs, hazard ratios; mirna, microrna; OR, overall survival; PFS, progression-free survival. Introduction Ovarian cancer represents the second most common gynecological malignancy (after cervical cancer) and accounts for over half of all deaths among women with gynecological neoplasms (1). The prognosis of ovarian cancer is proven to strongly depend on the disease stage at the time of diagnosis: the 5-year survival rate for patients with stage I disease (ovary confined) is 90% and this rate dramatically decreases to around 20% for those with advanced stages (stage III IV) (2). Given the poor survival of women with ovarian cancer, there is a pressing clinical demand to search for prognostic biomarkers for effectively evaluating the outcomes of this disease. MicroRNAs (mirnas), a class of small non-coding RNAs that control gene expression by targeting messenger RNA, are proposed as promising diagnostic and prognostic markers for various cancers (3 8), including ovarian Key Message Enhanced expression of mir-200c significantly improved survival outcome of ovarian cancer patients, especially those from Asia. ª 2016 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 95 (2016)
2 mir-200 family in ovarian cancer C. Shi & Z. Zhang cancer. mir-200, a family of tumor suppressor mirnas consisting of mir-141, mir-200a, mir-200b, mir-200c and mir-429, is significantly involved in the inhibition of epithelial-to-mesenchymal transition, repression of cancer stem cell self-renewal and differentiation, modulation of cell division and apoptosis, and reversal of chemoresistance (9). The related pathway of mir-141, mir-200a, mir-200b, mir-200c and mir-429 is mir- NAs in cancer. A study suggests that multiple mirnas of mir-200 family work together to prevent cancer cell metastasis by inhibiting the expression of involved key genes in the process (10). Hence, the mir-200 family mirnas may act as master regulators in ovarian cancer by targeting some cancer-related genes (10). In addition, Leskel a et al. suggested that the mir-200 family might be serving as a prognostic factor and a marker for treatment failure in ovarian cancer (11). Over the past few years, accumulating data appeared to verify the prognostic implications of the mir-200 family in women with ovarian cancer (10 15). Definitive conclusions, however, have not been drawn because of the limited sample size and inconsistent results across these studies. Therefore, it is necessary to evaluate the association of the mir-200 family expression with the survival of women with ovarian cancer by a metaanalysis. In our present study, we systematically searched the relevant articles and performed a meta-analysis to better evaluate the association between expression of the mir- 200 family and the survival of women with ovarian cancer. Material and methods A systematic literature search in PubMed, EMBASE and Cochrane Library was performed to identify articles that assessed the association between mir-200 family expression and the survival of women with ovarian cancer up to September The following terms: ( mir-200a OR mir-200b OR mir-200c OR mir-141 OR mir-429 ) AND ( ovarian cancer OR ovarian carcinoma ) AND ( prognosis OR survival ) were used for the search without language restriction. The reference lists of eligible articles were also screened for additional articles. Studies were included if they: (i) evaluated the association between mir-200 family expression and overall survival (OS)/progression-free survival (PFS) in patients with ovarian cancer; and (ii) provided sufficient information to calculate hazard ratios (HRs) and their 95% CIs. For studies with multiple publications focused on the same study population or studies with duplicate results published in different journals, we included only the most recent and complete study. Reviews, reports, letters, comments and studies that did not provide sufficient data were excluded. With a pre-designed form (Table 1), two investigators (CS and ZZ) independently extracted the following data from each study: first author, publication year, study location, number of patients, types of mirna, and HR, LCI (lower confidence interval) and UCI (upper confidence interval) of OS and PFS. Any discrepancies were resolved by discussion. Quality of included studies was Table 1. Characteristics of studies included in the meta-analysis. Study Year Sample size Country RNA HR (OS) LCI (OS) UCI (OS) HR (PFS) LCI (PFS) UCI (PFS) Type of data Cao China mir-200a High vs. Low Cao China mir-200b High vs. Low Cao China mir-200c High vs. Low Gao China mir-200c High vs. Low Gao China mir High vs. Low Leskel a Spain mir Continuous Leskel a Spain mir-200a Continuous Leskel a Spain mir-200b Continuous Leskel a Spain mir-200c Continuous Leskel a Spain mir Continuous Marchini Italy mir-200b High vs. Low Marchini Italy mir-200c High vs. Low Marchini Italy mir-200c High vs. Low Hu USA mir-200a High vs. Low Mateescu France mir-200a/ High vs. Low Sun China mir-200a High vs. Low HR, hazard ratio; LCI, lower confidence interval; UCI, upper confidence interval; OS, overall survival; PFS, progression-free survival. High vs. Low, high mirna expression versus low mirna expression. Continuous, continuous data of mirna expression. 506 ª 2016 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 95 (2016)
3 C. Shi & Z. Zhang mir-200 family in ovarian cancer assessed using the Newcastle Ottawa Scale (16) ( which is a validated technique for assessing the quality of observational and non-randomized studies. The scale uses a star system based on three criteria: participant selection, comparability of study groups and assessment of outcome or exposure. There were nine stars in total, one star for each item, except for the item Comparability of cohorts on the basis of the design or analysis, which possesses two stars. We have followed the PRISMA guidelines to report this meta-analysis. Statistical analysis Summary HRs and 95% CIs were calculated by using a random effects model (inverse-variance method) to assess the prognostic value of mir-200 family expression for the survival of women with ovarian cancer. The heterogeneity across studies was examined using Cochran s Q Figure 1. Flow diagram indicating the process of study selection for meta-analysis. statistic and the I 2 statistic (17). Subgroup analyses stratified by study location and the mir-200 family members (mir-200a, mir-200b and mir-200c) were conducted. Publication bias was assessed by Egger s test (18). Data analyses were performed with STATA 12.0 version software (19). A p-value <0.05 was considered statistically significant. One study at a time was trimmed to assess the sensitivity of the meta-analysis. The pooled results before and after the trim were compared and a reversed difference after the trim indicated unstable results. Results Figure 1 shows the process of study selection. According to the search strategy, a total of 79 articles were initially retrieved. After trimming the duplicate literature (n = 28), unrelated studies (n =31), and summaries, letters and conference excerpts (n = 5), 15 studies remained for further screening of the full-text. After eliminating eight articles without required data, seven studies were included in this meta-analysis (10 15,20). These eligible studies consisted of 16 sets of data with 553 women. Detailed characteristics of the included studies are presented in Table 1. As indicated by the result of the quality assessment, all the included studies have relatively high quality with six to nine stars (Table 2). The results of pooled analysis are shown in Table 3. Overall, significantly improved OS/PFS were observed with higher expression of the mir-200 family in women with ovarian cancer (OS, HR = 0.34, 95% CI ; PFS, HR = 0.64, 95% CI , Figure 2). Stratified analysis by mir-200 family member types revealed that there was a significant association between enhanced expression of mir-200c and improved OS (HR = 0.20, 95% CI ) and PFS (HR = 0.30, 95% CI , Figure 3), but there was no significant association with respect to mir-200a or mir-200b. Moreover, a Table 2. Methodological quality of studies included in the meta-analysis. Study Cao Gao Leskel a Marchini Hu Mateescu Sun Representativeness of the exposed cohort Selection of the non-exposed cohort Ascertainment of exposure Demonstration that outcome of interest was not present at start of study Comparability of cohorts on the basis of the design or analysis Assessment of outcome Was follow up long enough for outcomes to occur Adequacy of follow up of cohorts Stars ª 2016 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 95 (2016)
4 mir-200 family in ovarian cancer C. Shi & Z. Zhang Table 3. Results of quantitative analysis. Subgroup HR 95% CI I 2 (%) P H OS Overall Member type mir-200a mir-200b mir-200c Location Asia Europe PFS Overall Member type mir-200a mir-200b mir-200c HR, hazard ratio; OS, overall survival; PFS, progression free survival; P H,P heterogeneity. significant association was found between higher expression of the mir-200 family and improved OS in the Asian population (HR = 0.20, 95% CI , Figure 4), compared with the European population. The results of the heterogeneity test are shown in Table 3. There was significant heterogeneity across studies for the pooled analysis of the mir-200 family and OS (I 2 = 66.1%, p = 0.001), which might be caused by the studies involving mir-200b (I 2 = 91.2%, p = 0.001), because there was no significant heterogeneity across the studies involving mir-200a and mir-200c. Nor was significant heterogeneity found in the subgroup analysis of the studies of the European population. No significant heterogeneity existed across studies regarding mir-200 and PFS (I 2 = 44.0%, p = 0.065). As indicated by Egger s test, there was no significant publication bias for both OS (Egger s test, p = 0.097) and PFS (Egger s test, p = 0.234). (a) (b) Figure 2. Forest plots for the association between mir-200 expression and overall survival (a) progression-free survival (b) of patients with ovarian cancer. 508 ª 2016 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 95 (2016)
5 C. Shi & Z. Zhang mir-200 family in ovarian cancer (a) (b) Figure 3. Forest plots of subgroup analysis regarding specific mir-200 family member expression and overall survival (a) and progression-free survival (b) of patients with ovarian cancer. Sensitivity analyses of OS and PFS were performed. After trimming one study at a time, the pooled results did not reverse, indicating that the results of this metaanalysis were stable (Figure 5). Discussion In the current study, we assessed the association between mir-200 family expression and the survival of women with ovarian cancer. The pooled analysis of seven studies (16 sets of data with 553 women) demonstrated that higher expression of the mir-200 family significantly improved the OS and PFS in women with ovarian cancer. However, the subgroup analysis of mir-200 family members revealed that the improved OS and PFS existed only for enhanced expression of mir-200c. Moreover, a significant association between the expression of three mir-200 family members (mir-200a, mir- 200b and mir-200c) and favorable OS was observed in the Asian population. ª 2016 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 95 (2016)
6 mir-200 family in ovarian cancer C. Shi & Z. Zhang Figure 4. Forest plots of subgroup analysis by study location regarding the mir-200 family expression and overall survival of patients with ovarian cancer. (a) (b) Figure 5. Sensitivity analyses of studies regarding the overall survival (a) and progression free survival (b). It has been shown that mir-200s are accumulated in ovarian cancer (21 23). Expression of mir-200a, mir- 200b and mir-200c was significantly higher in ovarian cancer tissues than in normal ovarian epithelial tissues, and enhanced expression of these three members was significantly associated with poor OS (12). Furthermore, loss of mir-200c is parallel with increased expression of vascular endothelial growth factor A, which is targeted by mir-200c and relates to OS and PFS in multivariate analysis (13). In addition, Nam et al. suggested that overexpression of mir-200 family members was significantly associated with poor OS in women with ovarian cancer (24). Moreover, some studies indicated that high expression of mir-200s was associated with a favorable prognosis (10,21,25), and downregulation of mir-200s was related with relapse of ovarian cancer (13). Besides, the study of Hu et al. (10) indicated that low-level expression of three mir-200 family members (mir-200a, mir-200b and mir-429) was significantly associated with poor OS. The opposite results existed for mir-200b in the study of Marchini et al. (13), which might be caused by the different methods (mirna microarrays versus real-time RT- PCR) used for mirna detection and the samples (frozen tissue versus formalin-fixed, paraffin-embedded tissues) from other studies. Although the inconsistent results reported in these studies had not yet been interpreted comprehensively, part of the discrepancy might be attributed to the difference in microarray platforms since these mirna profiling studies were performed with different microarray 510 ª 2016 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 95 (2016)
7 C. Shi & Z. Zhang mir-200 family in ovarian cancer platforms. Besides, differences in experimental design across studies could also affect the interpretation of results. Notably, the insufficient number of tumor samples in the included studies could result in limited statistical power of the prognostic value of the mir-200 family. To our knowledge, this is the first meta-analysis to pool available data to evaluate the prognostic value of the mir-200 family in ovarian cancer. Our results of the meta-analysis are in line with most of the former researches and suggest that high expression of mir-200c may predict improved survival in women with ovarian cancer, and high expression of the mir-200 family significantly improves OS for Asian women. The protective effect of the mir-200 family for women with ovarian cancer found in our study might be explained by the potential suppressor role of mir-200 on malignant tumors by targeting ZEB1 and ZEB2 (members of the zinc-finger E- box binding homeobox family) (26 28). In addition, mir-200 could inhibit cancer stem cell self-renewal and differentiation, modulate cell division and apoptosis, and reverse chemoresistance (9). Moreover, it is proposed that specific members of the mir-200 family might be more important for prognosis of ovarian cancer (11). Hence, women would be benefited from a better understanding of the mir-200 family with regard to tumor suppressor roles of the mir-200 family in human cancer. Some limitations in our meta-analysis have to be acknowledged. First, pooled HR was calculated on the basis of 16 studies with a small sample size of 553 women. Second, significant heterogeneity was found across studies regarding the association of the mir-200 family with OS. Subgroup analysis showed that the main source of heterogeneity might result from studies on mir-200b. The inconsistent definition of OS/PFS, different types of disease, various sources of the sample and different methods/platforms for mrna detection might also introduce heterogeneity to this meta-analysis. Although a random effects model was used, we did not find the exact source of the heterogeneity. Third, this meta-analysis did not evaluate the prognostic value of a combination of mir-200 and other mirna markers for ovarian cancer. Conclusion This meta-analysis indicated that high expression of mir-200c may predict improved survival in women with ovarian cancer and high expression of the mir-200 family significantly improves OS for the Asian population. A comprehensive understanding of the tumor suppressor roles of the mir-200 family in ovarian cancer remains to be elucidated. Funding No specific funding. References 1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, CA Cancer J Clin. 2014;64: Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, et al. Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol. 2006;108: Cho W. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol. 2010;42: Oom AL, Humphries BA, Yang C. MicroRNAs: novel players in cancer diagnosis and therapies. Biomed Res Int. 2014;2014: Di Leva G, Croce CM. The role of micrornas in the tumorigenesis of ovarian cancer. Front Oncol. 2013;3: Cheng G. Circulating mirnas: roles in cancer diagnosis, prognosis and therapy. Adv Drug Deliv Rev. 2015;81: Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, et al. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007;67: Davidson B, Trope CG, Reich R. The clinical and diagnostic role of micrornas in ovarian carcinoma. Gynecol Oncol. 2014;133: Feng X, Wang Z, Fillmore R, Xi Y. MiR-200, a new star mirna in human cancer. Cancer Lett. 2014;344: Hu X, Macdonald DM, Huettner PC, Feng Z, El Naqa IM, Schwarz JK, et al. A mir-200 microrna cluster as prognostic marker in advanced ovarian cancer. Gynecol Oncol. 2009;114: Leskel a S, Leandro-Garcıa LJ, Mendiola M, Barriuso J, Inglada-Perez L, Mu~noz I, et al. The mir-200 family controls b-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr Relat Cancer. 2011;18: Cao Q, Lu K, Dai S, Hu Y, Fan W. Clinicopathological and prognostic implications of the mir-200 family in patients with epithelial ovarian cancer. Int J Clin Exp Pathol. 2014;7: Marchini S, Cavalieri D, Fruscio R, Calura E, Garavaglia D, Nerini IF, et al. Association between mir-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. Lancet Oncol. 2011;12: Mateescu B, Batista L, Cardon M, Gruosso T, De Feraudy Y, Mariani O, et al. mir-141 and mir-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med. 2011;17: ª 2016 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 95 (2016)
8 mir-200 family in ovarian cancer C. Shi & Z. Zhang 15. Sun Q, Zou X, Zhang T, Shen J, Yin Y, Xiang J. The role of mir-200a in vasculogenic mimicry and its clinical significance in ovarian cancer. Gynecol Oncol. 2014;132: Wells G, Shea B, O connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: The Ottawa Hospital Research Institute, Available online at: epidemiology/oxford.asp. 17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327: Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50: STATA. Stata version College Station, TX: StataCorp, Gao YC, Wu J. MicroRNA-200c and microrna-141 as potential diagnostic and prognostic biomarkers for ovarian cancer. Tumour Biol. 2015;36: Bendoraite A, Knouf EC, Garg KS, Parkin RK, Kroh EM, O briant KC, et al. Regulation of mir-200 family micrornas and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol Oncol. 2010;116: Yang H, Kong W, He L, Zhao J-J, O donnell JD, Wang J, et al. MicroRNA expression profiling in human ovarian cancer: mir-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008;68: Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O briant K, Godwin AK, et al. Repertoire of micrornas in epithelial ovarian cancer as determined by next generation sequencing of small RNA cdna libraries. PLoS ONE. 2009;4:e Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008;14: Eitan R, Kushnir M, Lithwick-Yanai G, David MB, Hoshen M, Glezerman M, et al. Tumor microrna expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecol Oncol. 2009;114: Korpal M, Lee ES, Hu G, Kang Y. The mir-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008;283: Park S-M, Gaur AB, Lengyel E, Peter ME. The mir-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008;22: Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10: ª 2016 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 95 (2016)
Review Article Prognostic Role of MicroRNA-200c-141 Cluster in Various Human Solid Malignant Neoplasms
Disease Markers Volume 2015, Article ID 935626, 19 pages http://dx.doi.org/10.1155/2015/935626 Review Article Prognostic Role of MicroRNA-200c-141 Cluster in Various Human Solid Malignant Neoplasms Xiao-yang
More informationAssociation of mir-21 with esophageal cancer prognosis: a meta-analysis
Association of mir-21 with esophageal cancer prognosis: a meta-analysis S.-W. Wen 1, Y.-F. Zhang 1, Y. Li 1, Z.-X. Liu 2, H.-L. Lv 1, Z.-H. Li 1, Y.-Z. Xu 1, Y.-G. Zhu 1 and Z.-Q. Tian 1 1 Department of
More informationThe Expression of Beclin-1 in Hepatocellular Carcinoma and Non-Tumor Liver Tissue: A Meta-Analysis
The Expression of Beclin-1 in Hepatocellular Carcinoma and Non-Tumor Liver Tissue: A Meta-Analysis Zhiqiang Qin¹, Xinjuan Yu², Jinkun Wu¹, Mei Lin¹ 1 Department of Pathology, School of Basic Medicine,
More informationSerum mir-200c expression level as a prognostic biomarker for gastric cancer
Serum mir-200c expression level as a prognostic biomarker for gastric cancer H.-P. Zhang 1 *, F.-B. Sun 2 * and S.-J. Li 2 1 Department of Gastrointestinal Surgery, Yantai Yuhuangding Hospital, Yantai,
More informationA systemic review and meta-analysis for prognostic values of pretreatment lymphocyte-to-monocyte ratio on gastric cancer
831094EJI0010.1177/2058739219831094European Journal of InflammationLi et al. letter2019 Letter to the Editor A systemic review and meta-analysis for prognostic values of pretreatment lymphocyte-to-monocyte
More informationCancer Cell Research 17 (2018)
Available at http:// www.cancercellresearch.org ISSN 2161-2609 Prognostic value of MicroRNA-21 in non-small cell lung cancer: a meta-analysis Fei Xu, Leina Ma, Lingxin Feng, Yinjie Wu, Xiaoyan Xu, Zhuang
More informationReview Article Long Noncoding RNA H19 in Digestive System Cancers: A Meta-Analysis of Its Association with Pathological Features
BioMed Research International Volume 2016, Article ID 4863609, 8 pages http://dx.doi.org/10.1155/2016/4863609 Review Article Long Noncoding RNA H19 in Digestive System Cancers: A Meta-Analysis of Its Association
More informationThe association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis
Wang et al. Journal of Ovarian Research (2016) 9:23 DOI 10.1186/s13048-016-0231-1 RESEARCH The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis
More informationMir-595 is a significant indicator of poor patient prognosis in epithelial ovarian cancer
European Review for Medical and Pharmacological Sciences 2017; 21: 4278-4282 Mir-595 is a significant indicator of poor patient prognosis in epithelial ovarian cancer Q.-H. ZHOU 1, Y.-M. ZHAO 2, L.-L.
More informationOriginal Article Lack of association between bcl-2 expression and prognosis of osteosarcoma: a meta-analysis
Int J Clin Exp Med 2015;8(6):9093-9099 www.ijcem.com /ISSN:1940-5901/IJCEM0008614 Original Article Lack of association between bcl-2 expression and prognosis of osteosarcoma: a meta-analysis Tao Fu 1*,
More informationOriginal Article microrna-217 was downregulated in ovarian cancer and was associated with poor prognosis
Int J Clin Exp Pathol 2016;9(8):8555-8559 www.ijcep.com /ISSN:1936-2625/IJCEP0026997 Original Article microrna-217 was downregulated in ovarian cancer and was associated with poor prognosis Qiong Pan,
More informationDownregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases
Brief Communication Downregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases Qinghai Zeng 1 *, Cuihong Jin 2 *, Wenhang Chen 2, Fang Xia 3, Qi Wang 3, Fan Fan 4,
More informationThe diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer
European Review for Medical and Pharmacological Sciences 2017; 21: 4039-4044 The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer H.-Y. FAN
More informationLack of association between IL-6-174G>C polymorphism and lung cancer: a metaanalysis
Lack of association between IL-6-174G>C polymorphism and lung cancer: a metaanalysis Y. Liu, X.L. Song, G.L. Zhang, A.M. Peng, P.F. Fu, P. Li, M. Tan, X. Li, M. Li and C.H. Wang Department of Respiratory
More informationMicroRNA-92gene expression in epithelial ovarian cancer using a novel Real-Time Polymerase change reaction
www.muthjm.com Muthanna Medical Journal 2016; 3(1):23-33 MicroRNA-92gene expression in epithelial ovarian cancer using a novel Real-Time Polymerase change reaction Shoroq Mohammed AL-Temimi 1* Abstract
More informationLow levels of serum mir-99a is a predictor of poor prognosis in breast cancer
Low levels of serum mir-99a is a predictor of poor prognosis in breast cancer J. Li 1, Z.J. Song 2, Y.Y. Wang 1, Y. Yin 1, Y. Liu 1 and X. Nan 1 1 Tumor Research Department, Shaanxi Provincial Tumor Hospital,
More informationReview Article Elevated expression of long noncoding RNA UCA1 can predict a poor prognosis: a meta-analysis
Int J Clin Exp Med 2016;9(6):9656-9664 www.ijcem.com /ISSN:1940-5901/IJCEM0025465 Review Article Elevated expression of long noncoding RNA UCA1 can predict a poor prognosis: a meta-analysis Tao Chen 1*,
More informationExpression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer
European Review for Medical and Pharmacological Sciences 2018; 22: 5525-5530 Expression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer Y.-X. SHI, B.-L. YE, B.-R. HU, X.-J.
More informationAssociation between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk
Association between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk B.B. Sun, J.Z. Wu, Y.G. Li and L.J. Ma Department of Respiratory Medicine, People s Hospital Affiliated to
More informationAlectinib Versus Crizotinib for Previously Untreated Alk-positive Advanced Non-small Cell Lung Cancer : A Meta-Analysis
Showa Univ J Med Sci 30 2, 309 315, June 2018 Original Alectinib Versus Crizotinib for Previously Untreated Alk-positive Advanced Non-small Cell Lung Cancer : A Meta-Analysis Ryo MANABE 1, Koichi ANDO
More informationExpression of mir-146a-5p in patients with intracranial aneurysms and its association with prognosis
European Review for Medical and Pharmacological Sciences 2018; 22: 726-730 Expression of mir-146a-5p in patients with intracranial aneurysms and its association with prognosis H.-L. ZHANG 1, L. LI 2, C.-J.
More informationClinical significance of serum mir-196a in cervical intraepithelial neoplasia and cervical cancer
Clinical significance of serum mir-196a in cervical intraepithelial neoplasia and cervical cancer P. Liu 1, F. Xin 1 and C.F. Ma 2 1 Department of Obstetrics & Gynecology, Baoding Second Central Hospital,
More informationDecreased expression of mir-490-3p in osteosarcoma and its clinical significance
European Review for Medical and Pharmacological Sciences Decreased expression of mir-490-3p in osteosarcoma and its clinical significance B. TANG, C. LIU, Q.-M. ZHANG, M. NI Department of Orthopedics,
More informationDiagnostic performance of microrna-29a for colorectal cancer: a meta-analysis
Diagnostic performance of microrna-29a for colorectal cancer: a meta-analysis M.L. Zhi 1 *, Z.J. Liu 2 *, X.Y. Yi 1, L.J. Zhang 1 and Y.X. Bao 1 1 Department of Clinical Laboratory, The Second Affiliated
More informationCancer Cell Research 19 (2018)
Available at http:// www.cancercellresearch.org ISSN 2161-2609 LncRNA RP11-597D13.9 expression and clinical significance in serous Ovarian Cancer based on TCGA database Xiaoyan Gu 1, Pengfei Xu 2, Sujuan
More informationThe Expression of Tumor-Derived and Stromal-Derived Matrix Metalloproteinase 2 Predicted Prognosis of Ovarian Cancer
ORIGINAL STUDY The Expression of Tumor-Derived and Stromal-Derived Matrix Metalloproteinase 2 Predicted Prognosis of Ovarian Cancer Ziyi Fu, MD,* Sujuan Xu, MD,Þ Ye Xu, MD,Þ Jiehua Ma, MD,* Jingyun Li,
More informationZhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou 1,2,3 Author affiliation:
Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: AMeta-analysis of Prospective Studies Zhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou
More informationReliability of Echocardiography Measurement of Patent Ductus Arteriosus Minimum Diameter: A Meta-analysis
International Journal of Cardiovascular and Cerebrovascular Disease 4(): 15-19, 016 DOI: 10.13189/ijccd.016.04001 http://www.hrpub.org Reliability of Echocardiography Measurement of Patent Ductus Arteriosus
More informationDownregulation of long non-coding RNA LINC01133 is predictive of poor prognosis in colorectal cancer patients
European Review for Medical and Pharmacological Sciences 2017; 21: 2103-2107 Downregulation of long non-coding RNA LINC01133 is predictive of poor prognosis in colorectal cancer patients J.-H. ZHANG 1,
More informationA meta-analysis of the effect of microrna-34a on the progression and prognosis of gastric cancer
European Review for Medical and Pharmacological Sciences 2018; 22: 8281-8287 A meta-analysis of the effect of microrna-34a on the progression and prognosis of gastric cancer Z. LI 1, Z.-M. LIU 2, B.-H.
More informationBridging anticoagulant therapy early after mechanical heart. valve surgery: systematic review with meta-analysis.
Bridging anticoagulant therapy early after mechanical heart valve surgery: systematic review with meta-analysis. Luiz Guilherme Passaglia, MD; Guilherme M. Barros, MD; Marcos R. de Sousa, MD, MSc, PhD.
More informationOn the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles
On the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles Ying-Wooi Wan 1,2,4, Claire M. Mach 2,3, Genevera I. Allen 1,7,8, Matthew L. Anderson 2,4,5 *, Zhandong Liu 1,5,6,7 * 1 Departments of Pediatrics
More informationExpression of long non-coding RNA linc-itgb1 in breast cancer and its influence on prognosis and survival
European Review for Medical and Pharmacological Sciences 2017; 21: 3397-3401 Expression of long non-coding RNA linc-itgb1 in breast cancer and its influence on prognosis and survival W.-X. LI 1, R.-L.
More informationOriginal Article Correlation between serum high-density lipoprotein level and senile dementia risk: a meta analysis
Int J Clin Exp Med 2016;9(8):15243-15248 www.ijcem.com /ISSN:1940-5901/IJCEM0020697 Original Article Correlation between serum high-density lipoprotein level and senile dementia risk: a meta analysis Yu
More informationSurveillance report Published: 17 March 2016 nice.org.uk
Surveillance report 2016 Ovarian Cancer (2011) NICE guideline CG122 Surveillance report Published: 17 March 2016 nice.org.uk NICE 2016. All rights reserved. Contents Surveillance decision... 3 Reason for
More informationAssociation between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis
Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis Y. Liu, H.L. Liu, W. Han, S.J. Yu and J. Zhang Department of Cardiology, The General Hospital of the
More informationOriginal Article Reduced serum mir-138 is associated with poor prognosis of head and neck squamous cell carcinoma
Int J Clin Exp Pathol 2017;10(10):10276-10281 www.ijcep.com /ISSN:1936-2625/IJCEP0059849 Original Article Reduced serum mir-138 is associated with poor prognosis of head and neck squamous cell carcinoma
More informationExpression of lncrna TCONS_ in hepatocellular carcinoma and its influence on prognosis and survival
European Review for Medical and Pharmacological Sciences 2017; 21: 5655-5660 Expression of lncrna TCONS_00027978 in hepatocellular carcinoma and its influence on prognosis and survival Q. CHEN 1, G.-D.
More informationAssociation between downexpression of mir-1301 and poor prognosis in patients with glioma
European Review for Medical and Pharmacological Sciences 2017; 21: 4298-4303 Association between downexpression of mir-1301 and poor prognosis in patients with glioma Q.-L. BAI, C.-W. HU, X.-R. WANG, G.-F.
More informationProfiles of gene expression & diagnosis/prognosis of cancer. MCs in Advanced Genetics Ainoa Planas Riverola
Profiles of gene expression & diagnosis/prognosis of cancer MCs in Advanced Genetics Ainoa Planas Riverola Gene expression profiles Gene expression profiling Used in molecular biology, it measures the
More informationCancerous esophageal stenosis before treatment was significantly correlated to poor prognosis of patients with esophageal cancer: a meta-analysis
Original Article Cancerous before treatment was significantly correlated to poor prognosis of patients with cancer: a meta-analysis Han-Yu Deng 1,2#, Guha Alai 1#, Jun Luo 1#, Gang Li 1, Ze-Guo Zhuo 1,
More informationmir-218 tissue expression level is associated with aggressive progression of gastric cancer
mir-218 tissue expression level is associated with aggressive progression of gastric cancer X.X. Wang 1, S.J. Ge 2, X.L. Wang 2, L.X. Jiang 1, M.F. Sheng 2 and J.J. Ma 2 1 Department of General Surgery,
More informationCORRELATION BETWEEN SURVIVIN OVEREXPRESSION AND CLINICO-PATHOLOGICAL FEATURES OF INVASIVE CERVICAL CANCER: A META-ANALYSIS
Acta Medica Mediterranea, 2018, 34: 1091 CORRELATION BETWEEN SURVIVIN OVEREXPRESSION AND CLINICO-PATHOLOGICAL FEATURES OF INVASIVE CERVICAL CANCER: A META-ANALYSIS HUI-RONG LI 1, JI-LI BAI 2*, RUI XU 2,
More informationPooled analysis of association between a genetic variant in the 3'-untranslated region of Toll-like receptor 4 and cancer risk
Pooled analysis of association between a genetic variant in the 3'-untranslated region of Toll-like receptor 4 and cancer risk X. Wang*, Z. Xu* and C.H. Miao Department of Anesthesiology, Shanghai Cancer
More informationThe Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer
Welcome! The Presence and Persistence of Resistant and Stem Cell- Like Tumor Cells as a Major Problem in Ovarian Cancer Prof. Sabine Kasimir-Bauer Department of Gynecology and Obstetrics University Hospital
More informationSingle nucleotide polymorphisms in ZNRD1-AS1 increase cancer risk in an Asian population
/, 2017, Vol. 8, (No. 6), pp: 10064-10070 Single nucleotide polymorphisms in ZNRD1-AS1 increase cancer risk in an Asian population Ping-Yu Wang 1,2, Jing-Hua Li 2, Yue-Mei Liu 1, Qing Lv 1, Ning Xie 3,
More informationPrognostic value of neutrophil to lymphocyte ratio in patients with nasopharyngeal carcinoma: A meta-analysis.
Biomedical Research 2017; 28 (3): 1378-1382 ISSN 0970-938X www.biomedres.info Prognostic value of neutrophil to lymphocyte ratio in patients with nasopharyngeal carcinoma: A meta-analysis. Bin Yu 1,2,
More informationOriginal Article Up-regulation of mir-10a and down-regulation of mir-148b serve as potential prognostic biomarkers for osteosarcoma
Int J Clin Exp Pathol 2016;9(1):186-190 www.ijcep.com /ISSN:1936-2625/IJCEP0018032 Original Article Up-regulation of mir-10a and down-regulation of mir-148b serve as potential prognostic biomarkers for
More informationCircular RNA_LARP4 is lower expressed and serves as a potential biomarker of ovarian cancer prognosis
European Review for Medical and Pharmacological Sciences 2018; 22: 7178-7182 Circular RNA_LARP4 is lower expressed and serves as a potential biomarker of ovarian cancer prognosis T. ZOU, P.-L. WANG, Y.
More informationAmerican Journal of Internal Medicine
American Journal of Internal Medicine 2016; 4(3): 49-59 http://www.sciencepublishinggroup.com/j/ajim doi: 10.11648/j.ajim.20160403.12 ISSN: 2330-4316 (Print); ISSN: 2330-4324 (Online) The Effect of Dose-Reduced
More information95% CI: , P=0.037).
Biomedical Research 2017; 28 (21): 9248-9252 Reduced expression level of mir-205 predicts poor prognosis in Qiang Yang 1*#, Peng Sun 2#, Haotian Feng 1, Xin Li 1, Jianmin Li 1 1 Department of Orthopedics,
More informationLong non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer
European Review for Medical and Pharmacological Sciences 2018; 22: 3357-3362 Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer H.-H. ZHANG
More informationReview Article Effect of mir-200b on metastasis of gastric cancer
Am J Digest Dis 2017;4(1):1-5 www.ajdd.us /ISSN:2329-6992/AJDD0040112 Review Article Effect of mir-200b on metastasis of gastric cancer Leyu Chiu 1, Brock Humphries 2,3 1 College of Human Medicine, 2 Department
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationThe angiotensin-converting enzyme (ACE) I/D polymorphism in Parkinson s disease
4432JRA0010.1177/1470320313494432Journal of the Renin-Angiotensin-Aldosterone SystemSu et al Original Article The angiotensin-converting enzyme (ACE) I/D polymorphism in Parkinson s disease Journal of
More informationStudy on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value
Study on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value Shen Wei 1,a, Chen Juan 2, Li Xiurong 1 and Yin Jie 1 1 Department of Obstetrics and Gynecology,
More informationThe QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews
The QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews David Moher 1, Alessandro Liberati 2, Douglas G Altman 3, Jennifer Tetzlaff 1 for the QUOROM Group
More informationResearch Article Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis
Disease Markers Volume 2015, Article ID 568980, 7 pages http://dx.doi.org/10.1155/2015/568980 Research Article Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis
More informationOriginal Article High serum mir-203 predicts the poor prognosis in patients with pancreatic cancer
Int J Clin Exp Pathol 2017;10(4):4688-4693 www.ijcep.com /ISSN:1936-2625/IJCEP0047128 Original Article High serum mir-203 predicts the poor prognosis in patients with pancreatic cancer Jun Ma, Xiaokun
More informationThe Prognostic Value of mir-21 and mir-155 in Non-small-cell Lung Cancer: A Meta-analysis
Jpn J Clin Oncol 2013;43(8)813 820 doi:10.1093/jjco/hyt084 Advance Access Publication 30 June 2013 The Prognostic Value of mir-21 and mir-155 in Non-small-cell Lung Cancer: A Meta-analysis Yan Wang 1,,
More informationOverexpression of long-noncoding RNA ZFAS1 decreases survival in human NSCLC patients
European Review for Medical and Pharmacological Sciences 2016; 20: 5126-5131 Overexpression of long-noncoding RNA ZFAS1 decreases survival in human NSCLC patients F.-M. TIAN 1, F.-Q. MENG 2, X.-B. WANG
More informationTitle:Identification of a novel microrna signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis
Author's response to reviews Title:Identification of a novel microrna signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis Authors: Mei-Yin Zhang (zhangmy@sysucc.org.cn) Shu-Hong
More informationOriginal Article Reduced expression of mir-506 in glioma is associated with advanced tumor progression and unfavorable prognosis
Int J Clin Exp Pathol 2016;9(1):181-185 www.ijcep.com /ISSN:1936-2625/IJCEP0017823 Original Article Reduced expression of mir-506 in glioma is associated with advanced tumor progression and unfavorable
More informationOriginal Article Downregulation of microrna-26b functions as a potential prognostic marker for osteosarcoma
Int J Clin Exp Pathol 2016;9(6):6506-6510 www.ijcep.com /ISSN:1936-2625/IJCEP0024531 Original Article Downregulation of microrna-26b functions as a potential prognostic marker for osteosarcoma Zhihong
More informationMicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL
MicroRNA expression profiling and functional analysis in prostate cancer Marco Folini s.c. Ricerca Traslazionale DOSL What are micrornas? For almost three decades, the alteration of protein-coding genes
More informationCapture-recapture method for assessing publication bias
Received: 30.9.2009 Accepted: 19.1.2010 Original Article Capture-recapture method for assessing publication bias Jalal Poorolajal* a, Ali Akbar Haghdoost b, Mahmood Mahmoodi a, Reza Majdzadeh a, Siavosh
More informationEditorial Process: Submission:07/30/2017 Acceptance:04/03/2018
DOI:10.22034/APJCP.2018.19.5.1169 REVIEW Editorial Process: Submission:07/30/2017 Acceptance:04/03/2018 Effectiveness of Platinum-Based Treatment for Triple Negative Metastatic Breast Cancer: a Meta-Analysis
More informationThe prognostic value of mir 126 expression in non small cell lung cancer: a meta analysis
DOI 10.1186/s12935-017-0440-8 Cancer Cell International PRIMARY RESEARCH The prognostic value of mir 126 expression in non small cell lung cancer: a meta analysis Wen Zheng 1, Ya Zhou 2, Jia Lu 1, Hualin
More informationThe Diagnostic and Prognostic Role of Serum MicroRNAs in Ovarian Cancer
The Diagnostic and Prognostic Role of Serum MicroRNAs in Ovarian Cancer Yin Min (First author) Medical College of Qingdao University, Qingdao, Shandong Province, China Chen Aiping (Corresponding author)
More informationSmall cell lung cancer (SCLC) accounts for approximately
ORIGINAL ARTICLE A Meta-Analysis of Randomized Controlled Trials Comparing Irinotecan/Platinum with Etoposide/Platinum in Patients with Previously Untreated Extensive-Stage Small Cell Lung Cancer Jingwei
More informationOriginal Article Zinc finger and BTB domain containing 20 rs polymorphism might decrease gastric cancer risk: a meta-analysis
Int J Clin Exp Med 2016;9(6):9225-9230 www.ijcem.com /ISSN:1940-5901/IJCEM0018045 Original Article Zinc finger and BTB domain containing 20 rs9841504 polymorphism might decrease gastric cancer risk: a
More informationLong noncoding RNA linc-ubc1 promotes tumor invasion and metastasis by regulating EZH2 and repressing E-cadherin in esophageal squamous cell carcinoma
JBUON 2018; 23(1): 157-162 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Long noncoding RNA linc-ubc1 promotes tumor invasion and metastasis
More informationHigh expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.
Biomedical Research 2017; 28 (18): 7779-7783 ISSN 0970-938X www.biomedres.info High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Hu Song 1, Qi-yu Liu 2, Zhi-wei
More informationDown-regulation of long non-coding RNA MEG3 serves as an unfavorable risk factor for survival of patients with breast cancer
European Review for Medical and Pharmacological Sciences 2016; 20: 5143-5147 Down-regulation of long non-coding RNA MEG3 serves as an unfavorable risk factor for survival of patients with breast cancer
More informationRelationship between RUNX3 methylation and hepatocellular carcinoma in Asian populations: a systematic review
Relationship between RUNX3 methylation and hepatocellular carcinoma in Asian populations: a systematic review X.X. Lu 1,2 *, L.Q. Zhu 1,2 *, F. Pang 3, W. Sun 1,2, C. Ou 1, Y. Li 1, J. Cao 1 and Y.L. Hu
More informationRESEARCH ARTICLE. Ai-Qiu Qin 1&, Zhong-Guo Liang 2&, Jia-Xiang Ye 3 *, Jing Li 1, Jian-Li Wang 1, Chang-Xian Chen 1, Hong-Lin Song 1 * Abstract
10.14456/apjcp.2016.196/APJCP.2016.17..3945 RESEARCH ARTICLE Significant Efficacy of Additional Concurrent Chemotherapy with Radiotherapy for Postoperative Cervical Cancer with Risk Factors: a Systematic
More informationIntroduction. Acta Medica Mediterranea, 2018, 34: 1441 ABSTRACT
Acta Medica Mediterranea, 2018, 34: 1441 A META-ANALYSIS OF THE RELATIONSHIP BETWEEN PROTEIN EXPRESSION OF HEDGEHOG SIGNALING PATHWAY AND INFECTION OF HUMAN PAPILLOMAVIRUS TYPE 16 IN CERVICAL CANCER XI-TONG
More informationCircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer
European Review for Medical and Pharmacological Sciences 2018; 22: 3713-3718 CircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer N. LIU 1, J. ZHANG 1, L.-Y. ZHANG 1, L.
More informationLong non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression
European Review for Medical and Pharmacological Sciences 2017; 21: 4087-4091 Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression C.-H. QU 1, Q.-Y.
More informationLong non-coding RNA Loc is a potential prognostic biomarker in non-small cell lung cancer
European Review for Medical and Pharmacological Sciences 2017; 21: 3808-3812 Long non-coding RNA Loc344887 is a potential prognostic biomarker in non-small cell lung cancer B. WU 1, X.-J. ZHANG 2, X.-G.
More informationClinical significance of up-regulated lncrna NEAT1 in prognosis of ovarian cancer
European Review for Medical and Pharmacological Sciences 2016; 20: 3373-3377 Clinical significance of up-regulated lncrna NEAT1 in prognosis of ovarian cancer Z.-J. CHEN, Z. ZHANG, B.-B. XIE, H.-Y. ZHANG
More informationOriginal Article Increased expression of microrna-196a predicts poor prognosis in human ovarian carcinoma
Int J Clin Exp Pathol 2015;8(4):4132-4137 www.ijcep.com /ISSN:1936-2625/IJCEP0006320 Original Article Increased expression of microrna-196a predicts poor prognosis in human ovarian carcinoma Yi Fan, Jin
More informationThe effect of resection of the primary tumour for stage IV colorectal cancer on patient survival: a systematic review and meta-analysis
The effect of resection of the primary tumour for stage IV colorectal cancer on patient survival: a systematic review and meta-analysis C.Clancy, J.P. Burke, M. Barry, M.F Kalady, J.C. Coffey Dept. of
More informationAnalysis of circulating long non-coding RNA UCA1 as potential biomarkers for diagnosis and prognosis of osteosarcoma
European Review for Medical and Pharmacological Sciences 2017; 21: 498-503 Analysis of circulating long non-coding RNA UCA1 as potential biomarkers for diagnosis and prognosis of osteosarcoma J.-J. WEN
More informationThe A10389G polymorphism of ND3 gene and breast cancer: A meta-analysis
BIOMEDICAL REPORTS 1: 259-264, 2013 The A10389G polymorphism of ND3 gene and breast cancer: A meta-analysis QUNXIA MAO 1*, LINGGEN GAO 2*, QING LIU 1, YAN ZOU 1, XVHUI YANG 3, HONGWEI WANG 4, QIAN WANG
More informationDATE: 22 May 2013 CONTEXT AND POLICY ISSUES
TITLE: Intraperitoneal versus Intravenous Chemotherapy for the Treatment of Ovarian Cancer: A Review of the Comparative Clinical Evidence, Safety, Cost- Effectiveness, and Guidelines DATE: 22 May 2013
More informationGenetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma
Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma M.J. Wang, Y. Zhu, X.J. Guo and Z.Z. Tian Department of Orthopaedics, Xinxiang Central Hospital, Xinxiang,
More informationIntroduction to REMARK: Reporting tumour marker prognostic studies
Introduction to REMARK: Reporting tumour marker prognostic studies Doug Altman The EQUATOR Network Centre for Statistics in Medicine, Oxford, UK C 1 S M Reliable research Reliability is determined by proper
More informationEvaluating the results of a Systematic Review/Meta- Analysis
Open Access Publication Evaluating the results of a Systematic Review/Meta- Analysis by Michael Turlik, DPM 1 The Foot and Ankle Online Journal 2 (7): 5 This is the second of two articles discussing the
More informationOriginal Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome
Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical
More informationOriginal Article Tissue expression level of lncrna UCA1 is a prognostic biomarker for colorectal cancer
Int J Clin Exp Pathol 2016;9(4):4241-4246 www.ijcep.com /ISSN:1936-2625/IJCEP0012296 Original Article Tissue expression level of lncrna UCA1 is a prognostic biomarker for colorectal cancer Hong Jiang,
More informationCotrimoxazole preventive therapy in adults and pregnant women with HIV: a systematic review and meta-analysis
Cotrimoxazole preventive therapy in adults and pregnant women with HIV: a systematic review and meta-analysis Introduction Global efforts to scale-up antiretroviral therapy (ART) averted an estimated 4.2
More informationReduced mirna-218 expression in pancreatic cancer patients as a predictor of poor prognosis
Reduced mirna-218 expression in pancreatic cancer patients as a predictor of poor prognosis B.-S. Li, H. Liu and W.-L. Yang Department of Gastrointestinal and Pancreatic Surgery, The Third Xiangya Hospital
More informationOriginal Article MicroRNA-27a acts as a novel biomarker in the diagnosis of patients with laryngeal squamous cell carcinoma
Int J Clin Exp Pathol 2016;9(2):2049-2053 www.ijcep.com /ISSN:1936-2625/IJCEP0014841 Original Article MicroRNA-27a acts as a novel biomarker in the diagnosis of patients with laryngeal squamous cell carcinoma
More informationPrognostic significance of the platelet-to-lymphocyte ratio in ovarian cancer: a meta-analysis
Original Article Prognostic significance of the platelet-to-lymphocyte ratio in ovarian cancer: a meta-analysis Weiyu Xu 1#, Wenqin Wang 2#, Min Yang 3#, Lina Song 4#, Jianping Xiong 1#, Jianzhen Lin 1,
More informationThe effect of delayed adjuvant chemotherapy on relapse of triplenegative
Original Article The effect of delayed adjuvant chemotherapy on relapse of triplenegative breast cancer Shuang Li 1#, Ding Ma 2#, Hao-Hong Shi 3#, Ke-Da Yu 2, Qiang Zhang 1 1 Department of Breast Surgery,
More informationReview Article Prognostic Value of MicroRNA-182 in Cancers: A Meta-Analysis
Disease Markers Volume 2015, Article ID 482146, 8 pages http://dx.doi.org/10.1155/2015/482146 Review Article Prognostic Value of MicroRNA-182 in Cancers: A Meta-Analysis Fei Wang, 1 Shanliang Zhong, 2
More informationPrognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis
Original Article Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis Jun Fan, Dali Chen, Heng Du, Cheng Shen, Guowei Che Department
More informationClinicopathologic and prognostic relevance of mir-1256 in colorectal cancer: a preliminary clinical study
European Review for Medical and Pharmacological Sciences 2018; 22: 7704-7709 Clinicopathologic and prognostic relevance of mir-1256 in colorectal cancer: a preliminary clinical study Z.-Y. LIU, L. YANG,
More informationNovel Biomarkers (Kallikreins) for Prognosis and Therapy Response in Ovarian cancer
Novel Biomarkers (Kallikreins) for Prognosis and Therapy Response in Ovarian cancer Eleftherios P. Diamandis, M.D., Ph.D., FRCP(C) EORTC-NCI-ASCO Meeting,November 16, 2007 Yousef GM, Diamandis EP. Endocr.
More information